Effects of Otago Exercise Program in Falls, Balance and Physical Performance in Stroke Patients
Launched by RIPHAH INTERNATIONAL UNIVERSITY · May 19, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the Otago Exercise Program (OEP) to see how it affects falls, balance, and overall physical performance in patients who have had a stroke. The trial will include two groups: one group will participate in the OEP, while the other group will not. Researchers will evaluate the participants' balance and physical ability using simple tests over the course of a week.
To be eligible for the trial, participants must be at least 40 years old and have experienced a stroke within the last six months. They should also have certain balance and mobility scores that indicate they could benefit from the exercise program. However, individuals with cognitive difficulties, significant physical disabilities other than from the stroke, recent surgeries, or certain health conditions like heart or lung diseases will not be included. If you or someone you know meets these criteria, this study could be a valuable opportunity to improve balance and reduce the risk of falls after a stroke.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ischemic or hemorrhagic stroke
- • Medically stable patients with acute to subacute level of stroke recovery (\< 6 month).
- • Patients 40 plus age
- • Berg balance scale \<45 and \>20 score
- • TUG test scoring \>20 sec
- Exclusion Criteria:
- • Participants having cognition problem or language barrier
- • Physical disability (fracture or amputation) other than stroke
- • Previous surgery 6 weeks
- • Cardiovascular and pulmonary disease
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Peshawar, Kpk, Pakistan
Patients applied
Trial Officials
IMRAN AMJAD, PhD
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported